GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced first quarter 2023 financial results and provided a business update.
“We had strong growth at Hyperfine in the first quarter of 2023 and delivered record revenue of $2.6 million. We remained focused on executing on our three strategic pillars of innovation, clinical evidence, and commercial expansion, while continuing to exercise financial discipline to extend our cash runway through the end of 2025,” said Maria Sainz, Chief Executive Officer and President of Hyperfine, Inc. “We are excited and committed to deliver on the vision to expand access to MRI for clinicians and their patients globally.”
Finančni rezultati za prvo četrtletje 2023
- Revenues for the first quarter of 2023 were $2.64 million, compared to $1.51 million in the first quarter of 2022.
- Hyperfine, Inc. installed 10 commercial Swoop systems in the first quarter of 2023.
- Gross margin for the first quarter of 2023 was $1.16 million, compared to $0.08 million in the first quarter of 2022.
- Research and development expenses for the first quarter of 2023 were $5.46 million, compared to $8.33 million in the first quarter of 2022.
- Sales, general, and administrative expenses for the first quarter of 2023 were $8.73 million, compared to $15.52 million in the first quarter of 2022.
- Net loss for the first quarter of 2023 was $12.16 million, equating to a net loss of $0.17 per share, as compared to a net loss of $23.78 million, or a net loss of $0.34 per share, for the same period of the prior year.
2023 Finančne smernice
- Management expects revenue for the full year 2023 to be $10 to $14 million.
- Management expects cash burn for the full year 2023 to be $40 to $45 million.
Konferenčni klic
Hyperfine, Inc. will host a conference call at 1:30 p.m. PT/ 4:30 p.m. ET on Thursday, May 11, 2023, to discuss its first quarter 2023 financial results and provide a business update. Those interested in listening should register online by visiting https://investors.hyperfine.io/. and clicking on News & Events. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived audio webcast will be available through the Investors page of Hyperfine, Inc.’s corporate website at https://investors.hyperfine.io/.
About Hyperfine, Inc. and the Swoop® Portable MR Imaging® System
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a bedside magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The Swoop® system has been approved for brain imaging in several countries, including Canada and Australia, has UKCA certification in the United Kingdom, CE certification in the European Union, and is also available in New Zealand.
The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging, and data solutions. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. Traditionally, access to costly, stationary, conventional MRI technology can be inconvenient or not available when needed most. With the portable, ultra-low-field Swoop® system, Hyperfine, Inc. is redefining the neuroimaging workflow by bringing brain imaging to the patient’s bedside. For more information, visit hyperfine.io.
Hyperfine, Swoop in Portable MR Imaging so registrirane blagovne znamke Hyperfine, Inc.
Napovedne izjave
To sporočilo za javnost vključuje "izjave, usmerjene v prihodnost" v smislu določb o "varnem pristanu" Zakona o reformi pravnih sporov o zasebnih vrednostnih papirjih iz leta 1995. Hyperfine, Inc. (the "Company”)’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Besede, kot so "pričakuj", "oceni", "projekt", "proračun", "napovedi", "predvidej", "nameravaj", "načrt", "lahko", "bo", "bi lahko", "bi moral, "" Verjame "," napoveduje "," potencial "," nadaljuje "in podobni izrazi (ali negativne različice takih besed ali izrazov) so namenjeni prepoznavanju takšnih napovednih izjav. These forward-looking statements include, without limitation, expectations about the Company’s financial and operating results, the Company’s commercial plans, the benefits of the Company’s products and services, and the Company’s future performance and its ability to implement its strategy. Te napovedne izjave vključujejo velika tveganja in negotovosti, zaradi katerih bi se dejanski rezultati lahko bistveno razlikovali od pričakovanih. Večina teh dejavnikov je zunaj nadzora podjetja in jih je težko predvideti. Factors that may cause such differences include, but are not limited to: the success, cost and timing of the Company’s product development and commercialization activities, including the degree that the Swoop® system is accepted and used by healthcare professionals; the impact of COVID-19 on the Company’s business; the inability to maintain the listing of the Company’s Class A common stock on the Nasdaq Stock Market LLC; the Company’s inability to grow and manage growth profitably and retain its key employees; changes in applicable laws or regulations; the inability of the Company to raise financing in the future; the inability of the Company to obtain and maintain regulatory clearance or approval for its products, and any related restrictions and limitations of any cleared or approved product; the inability of the Company to identify, in-license or acquire additional technology; the inability of the Company to maintain its existing or future license, manufacturing, supply and distribution agreements and to obtain adequate supply of its products; the inability of the Company to compete with other companies currently marketing or engaged in the development of products and services that the Company is currently marketing or developing; the size and growth potential of the markets for the Company’s products and services, and its ability to serve those markets, either alone or in partnership with others; the pricing of the Company’s products and services and reimbursement for medical procedures conducted using the Company’s products and services; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s financial performance; and other risks and uncertainties indicated from time to time in Company’s filings with the Securities and Exchange Commission, including those under “Risk Factors” therein. Družba opozarja bralce, da zgornji seznam dejavnikov ni izključujoč in da se bralci ne smejo pretirano zanašati na nobene napovedne izjave, ki veljajo samo za datum, ko so bili podani.
Kontakt z vlagatelji
Marissa Bych
Skupina Gilmartin LLC
marissa@gilmartinir.com
HYPERFINE, INC. AND SUBSIDIARIES
ZBIRAN KONSOLIDIRANI BILANČNI LISTI
(v tisoč, razen zneskov delnic in delnic)
(Nerevidirano)
Marca 31, 2023 | December 31, 2022 | |||||||
SREDSTVA | ||||||||
TEKOČA SREDSTVA: | ||||||||
Denar in denarni ustrezniki | $ | 104,027 | $ | 117,472 | ||||
Denarna sredstva z omejitvami | 713 | 771 | ||||||
Accounts receivable, less allowance of $191 and $180 as of March 31, 2023 and December 31, 2022, respectively | 3,018 | 2,103 | ||||||
Nezaračunane terjatve | 713 | 454 | ||||||
popis | 5,744 | 4,622 | ||||||
Vnaprej plačani odhodki in druga obratna sredstva | 2,923 | 3,194 | ||||||
Dolg od povezanih oseb | - | 48 | ||||||
Skupna kratkoročna sredstva | 117,138 | 128,664 | ||||||
Nepremičnine in oprema, neto | 3,091 | 3,248 | ||||||
Other long term assets | 1,873 | 2,139 | ||||||
Bilančna vsota | $ | 122,102 | $ | 134,051 | ||||
OBVEZNOSTI IN KAPITAL DELOVNIH DRUŽB | ||||||||
TEKOČE OBVEZNOSTI: | ||||||||
Obveznosti za plačilo | $ | 1,668 | $ | 678 | ||||
Deferred grant funding | 713 | 771 | ||||||
Odloženi prihodki | 1,415 | 1,378 | ||||||
Zaradi povezanih oseb | 64 | - | ||||||
Pasivne časovne razmejitve | 4,141 | 5,976 | ||||||
Skupne kratkoročne obveznosti | 8,001 | 8,803 | ||||||
Long term deferred revenue | 1,364 | 1,526 | ||||||
Skupaj obveznosti | 9,365 | 10,329 | ||||||
COMMITMENTS AND CONTINGENCIES (NOTE 12) | ||||||||
STOCKHOLDERS' EQUITY | ||||||||
Class A Common stock, $.0001 par value; 600,000,000 shares authorized; 56,000,995 and 55,622,488 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 5 | 5 | ||||||
Class B Common stock, $.0001 par value; 27,000,000 shares authorized; 15,055,288 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 2 | 2 | ||||||
Dodatni vplačani kapital | 334,374 | 333,199 | ||||||
Akumulirani primanjkljaj | (221,644 | ) | (209,484 | ) | ||||
Skupni delniški kapital | 112,737 | 123,722 | ||||||
SKUPNE OBVEZNOSTI IN DELNIŠKI KAPITAL | $ | 122,102 | $ | 134,051 |
HYPERFINE, INC. AND SUBSIDIARIES
ZBIRAN CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS
(v tisoč, razen zneskov delnic in delnic)
(Nerevidirano)
Končali tri mesece Marca 31, | ||||||||
2023 | 2022 | |||||||
Prodaja | ||||||||
Device | $ | 2,132 | $ | 1,192 | ||||
Service | 503 | 317 | ||||||
Skupna prodaja | 2,635 | 1,509 | ||||||
Stroški prodaje | ||||||||
Device | 1,071 | 1,037 | ||||||
Service | 409 | 388 | ||||||
Skupni stroški prodaje | 1,480 | 1,425 | ||||||
Bruto marža | 1,155 | 84 | ||||||
Poslovni odhodki: | ||||||||
Raziskave in razvoj | 5,461 | 8,334 | ||||||
Splošno in upravno | 6,182 | 11,360 | ||||||
Prodaja in trženje | 2,547 | 4,161 | ||||||
Skupni stroški poslovanja | 14,190 | 23,855 | ||||||
Izguba iz poslovanja | (13,035 | ) | (23,771 | ) | ||||
Dohodek od obresti | 869 | 1 | ||||||
Drugi prihodki (odhodki), neto | 6 | (5 | ) | |||||
Izguba pred rezervacijo za dohodnino | (12,160 | ) | (23,775 | ) | ||||
Rezervacije za dohodnino | - | - | ||||||
Čista izguba in obsežna izguba | $ | (12,160 | ) | $ | (23,775 | ) | ||
Net loss per common share attributable to common stockholders, basic and diluted | $ | (0.17 | ) | $ | (0.34 | ) | ||
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted | 70,864,226 | 70,332,349 |
HYPERFINE, INC. AND SUBSIDIARIES
ZBIRAN CONSOLIDATED STATEMENT OF CASH FLOWS
(v tisočih)
(Nerevidirano)
Končali tri mesece Marca 31, | ||||||||
2023 | 2022 | |||||||
Denarni tokovi iz poslovnih dejavnosti: | ||||||||
Čista izguba | $ | (12,160 | ) | $ | (23,775 | ) | ||
Prilagoditve za uskladitev čiste izgube z neto denarnimi sredstvi, uporabljenimi v poslovnih dejavnostih: | ||||||||
Amortizacija | 254 | 253 | ||||||
Stroški odškodnine na podlagi zalog | 1,126 | 4,111 | ||||||
Payments received on net investment in lease | 2 | 2 | ||||||
Spremembe sredstev in obveznosti: | ||||||||
Terjatve do kupcev | (915 | ) | (1,391 | ) | ||||
Nezaračunane terjatve | (259 | ) | (387 | ) | ||||
popis | (1,122 | ) | (228 | ) | ||||
Vnaprej plačani odhodki in druga obratna sredstva | 272 | (1,848 | ) | |||||
Dolg od povezanih oseb | 48 | 13 | ||||||
Predplačan inventar | 281 | - | ||||||
Other long term assets | (18 | ) | 11 | |||||
Obveznosti za plačilo | 954 | (565 | ) | |||||
Deferred grant funding | (58 | ) | (679 | ) | ||||
Odloženi prihodki | (125 | ) | 584 | |||||
Zaradi povezanih oseb | 64 | (1,884 | ) | |||||
Pasivne časovne razmejitve | (1,835 | ) | (1,506 | ) | ||||
Neto denarna sredstva, uporabljena v poslovnih dejavnostih | (13,491 | ) | (27,289 | ) | ||||
Denarni tokovi iz naložbenih dejavnosti: | ||||||||
Nabava nepremičnin in opreme | (61 | ) | (308 | ) | ||||
Neto denarna sredstva, uporabljena v naložbenih dejavnostih | (61 | ) | (308 | ) | ||||
Denarni tokovi iz dejavnosti financiranja: | ||||||||
Prihodki od uveljavljanja delniških opcij | 49 | - | ||||||
Neto denarna sredstva, zagotovljena s financiranjem | 49 | - | ||||||
Net (decrease) increase in cash and cash equivalents and restricted cash | (13,503 | ) | (27,597 | ) | ||||
Denarna sredstva, njihovi ustrezniki in omejena denarna sredstva, začetek obdobja | 118,243 | 191,160 | ||||||
Denarna sredstva, njihovi ustrezniki in omejena denarna sredstva, konec obdobja | 104,740 | 163,563 | ||||||
Reconciliation of cash, cash equivalents, and restricted cash reported in the balance sheets | ||||||||
Denar in denarni ustrezniki | 104,027 | 161,580 | ||||||
Denarna sredstva z omejitvami | 713 | 1,983 | ||||||
Skupaj denarna sredstva, njihovi ustrezniki in omejena denarna sredstva | $ | 104,740 | $ | 163,563 | ||||
Supplemental disclosure of noncash information: | ||||||||
Noncash acquisition of fixed assets | $ | 36 | $ | 62 | ||||
Write-off of notes receivable | $ | - | $ | 90 |
- Distribucija vsebine in PR s pomočjo SEO. Okrepite se še danes.
- PlatoAiStream. Podatkovna inteligenca Web3. Razširjeno znanje. Dostopite tukaj.
- Kovanje prihodnosti z Adryenn Ashley. Dostopite tukaj.
- Kupujte in prodajajte delnice podjetij pred IPO s PREIPO®. Dostopite tukaj.
- vir: https://www.biospace.com/article/releases/hyperfine-inc-reports-first-quarter-2023-financial-results/?s=93
- :ima
- : je
- :ne
- :kje
- ][str
- 000
- 1
- 10
- 11
- 12
- 13
- 15%
- 2020
- 2022
- 2023
- 2025
- 23
- 27
- 28
- 30
- 7
- a
- sposobnost
- O meni
- Sprejmi
- sprejeta
- dostop
- dostopen
- pridobiti
- pridobitev
- Zakon
- dejavnosti
- dejanska
- Dodatne
- uprava
- upravno
- Sporazumi
- sam
- Prav tako
- zneski
- in
- razglasitve
- kaj
- primerno
- Uporabi
- odobritev
- odobren
- SE
- AS
- Sredstva
- At
- audio
- Avstralija
- pooblaščeni
- Na voljo
- Ravnovesje
- temeljijo
- Osnovni
- BE
- bilo
- pred
- Začetek
- Prednosti
- BioSpace
- Brain
- Predložitev
- gorijo
- poslovni
- vendar
- by
- klic
- se imenuje
- CAN
- Kanada
- lahko
- Kapital
- kapitalske zahteve
- ki
- Denar
- Vzrok
- certificiranje
- spremenite
- Spremembe
- šef
- izvršni direktor
- okoliščinah
- razred
- klinični
- kliniki
- komercialna
- komercializacija
- Komisija
- storjeno
- Skupno
- skupna zaloga
- Podjetja
- podjetje
- Podjetja
- v primerjavi z letom
- Odškodnina
- tekmujejo
- celovito
- Izračunajte
- Pogoji
- poteka
- Konferenca
- Posledično
- nadaljevati
- nadzor
- konvencionalne
- Corporate
- strošek
- bi
- države
- Covid-19
- ustvaril
- CSS
- Trenutna
- Trenutno
- datum
- Datum
- december
- zmanjša
- Stopnja
- poda
- dostavi
- določanje
- razvili
- razvoju
- Razvoj
- naprava
- Diagnostično slikanje
- se razlikujejo
- razlike
- težko
- razkritje
- razpravlja
- zaslon
- distribucija
- ne
- drog
- E&T
- bodisi
- Zaposleni
- spodbujati
- konec
- , ki se ukvarjajo
- Inženirji
- oprema
- ekvivalenti
- ocene
- Eter (ETH)
- Evropski
- Evropska unija
- dogodki
- dokazi
- Razen
- Izmenjava
- razburjen
- Ekskluzivno
- izvršitve
- izvršni
- Izvršni direktor
- Vaja
- obstoječih
- Razširi
- Širitev
- pričakovanja
- Pričakuje
- pričakuje
- Stroški
- izrazi
- razširiti
- dejavniki
- FDA
- vložki
- finančna
- finančna disciplina
- finančna uspešnost
- financiranja
- prva
- Všita
- Tokovi
- osredotočena
- hrana
- Food and Drug Administration
- Uprava za hrano in zdravila (FDA)
- za
- v prihodnost
- Ustanovljeno
- iz
- polno
- Prihodnost
- splošno
- Globalno
- globus
- GLOBE NOVICE
- odobri
- prelomni
- skupina
- Grow
- Rast
- potencial rasti
- imel
- Glava
- zdravstveno varstvo
- gostitelj
- Kako
- HTTPS
- identificirati
- slike
- slikanje
- vpliv
- izvajati
- in
- nezmožnost
- Inc
- vključujejo
- vključuje
- Vključno
- prihodki
- Povečajte
- inkubator
- naveden
- Podatki
- začetna
- Inovacije
- namenjen
- zainteresirani
- notranji
- vlaganjem
- naložbe
- Vlagatelji
- vključujejo
- Izdala
- ITS
- Ključne
- Kraljestvo
- Zakoni
- manj
- obveznosti
- Licenca
- Omejitev
- omejitve
- Limited
- Seznam
- Poslušanje
- seznam
- Litigation
- v živo
- LLC
- logo
- Long
- off
- je
- vzdrževati
- upravljanje
- proizvodnja
- marec
- Marža
- Tržna
- Trženje
- Prisotnost
- materialno
- Maj ..
- kar pomeni,
- medicinski
- medicinski pripomoček
- Metodologija
- milijonov
- min
- Mission
- mesecev
- več
- Najbolj
- mr
- MRI
- Nasdaq
- potrebna
- potrebe
- negativna
- net
- Novo
- Nova Zelandija
- novice
- Newswire
- Opombe
- Obveznost
- pridobi
- of
- Častnik
- on
- na spletu
- samo
- deluje
- operacije
- or
- Ostalo
- drugi
- naši
- ven
- zunaj
- Neporavnani
- Stran
- Udeleženci
- Partnerstvo
- strast
- Bolnik
- skrb za bolnika
- bolniki
- performance
- Obdobje
- zdravnik
- Kraj
- načrti
- platon
- Platonova podatkovna inteligenca
- PlatoData
- Točka
- potencial
- Praktično
- napovedati
- Napovedi
- Predsednik
- pritisnite
- Sporočilo za javnost
- cenitev
- primarni
- Predhodna
- zasebna
- Postopki
- Izdelek
- Razvoj izdelkov
- Izdelki
- Izdelki in storitve
- strokovnjaki
- Napovedi
- nepremičnine
- zagotavljajo
- če
- zagotavljanje
- zagotavljanje
- javno
- četrtletje
- dvigniti
- bralci
- prejetih
- zapis
- Ponovna opredelitev
- odražajo
- Reforma
- o
- Registracija
- registriranih
- predpisi
- regulatorni
- povezane
- sprostitev
- pomembno
- odvisnost
- zanašajo
- ostalo
- Prijavljeno
- Poročila
- Zahteve
- resonanca
- omejeno
- Omejitve
- Rezultati
- ohranijo
- prihodki
- popravki
- revolucijo
- tveganja
- vzletno-pristajalne steze
- s
- Je dejal
- Enako
- Znanstveniki
- Vrednostni papirji
- Securities and Exchange Commission
- služijo
- Storitve
- več
- Delite s prijatelji, znanci, družino in partnerji :-)
- Delnice
- shouldnt
- pomemben
- Podoben
- Velikosti
- rešitve
- govorijo
- Začetek
- Izjava
- Izjave
- zaloge
- borza
- Strateško
- Strategija
- močna
- Struktura
- uspeh
- taka
- dobavi
- sistem
- sistemi
- Tehnologija
- kot
- da
- O
- Prihodnost
- Združeno kraljestvo
- svet
- njihove
- v njem
- te
- tisti,
- tisoče
- 3
- skozi
- četrtek
- čas
- čas
- do
- danes
- blagovne znamke
- tradicionalno
- usposobljeni
- transformacijski
- nas
- negotovosti
- pod
- unija
- Velika
- Anglija
- Nadgradnja
- posodobitve
- naprej
- Rabljeni
- uporabo
- vrednost
- Vizija
- obisk
- je
- we
- Spletna stran
- so bili
- kdaj
- ki
- medtem
- bo
- z
- v
- brez
- besede
- potek dela
- svet
- svetu
- leto
- jo
- Zelandija
- zefirnet